Analysts from PhillipCapital and UOB Kay Hian have kept their ‘buy’ calls on Keppel Corp with unchanged target prices of $6.12 and $6.37 respectively after the company announced it will be recognising an impairment loss of $318 million with respect to its exposure to KrisEnergy.


See: Keppel Corp to recognise impairment loss of $318 mil in 1H21 on exposure to KrisEnergy


The analysts from both brokerages highlight that the impairment is not expected to have an impact on Keppel’s FY2021 ending December final dividend, as Keppel has stated that it will ringfence the impairment loss.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook